Correlation Between Tanvex BioPharma and EirGenix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tanvex BioPharma and EirGenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tanvex BioPharma and EirGenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tanvex BioPharma and EirGenix, you can compare the effects of market volatilities on Tanvex BioPharma and EirGenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tanvex BioPharma with a short position of EirGenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tanvex BioPharma and EirGenix.

Diversification Opportunities for Tanvex BioPharma and EirGenix

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Tanvex and EirGenix is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Tanvex BioPharma and EirGenix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EirGenix and Tanvex BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tanvex BioPharma are associated (or correlated) with EirGenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EirGenix has no effect on the direction of Tanvex BioPharma i.e., Tanvex BioPharma and EirGenix go up and down completely randomly.

Pair Corralation between Tanvex BioPharma and EirGenix

Assuming the 90 days trading horizon Tanvex BioPharma is expected to generate 1.66 times more return on investment than EirGenix. However, Tanvex BioPharma is 1.66 times more volatile than EirGenix. It trades about 0.0 of its potential returns per unit of risk. EirGenix is currently generating about -0.02 per unit of risk. If you would invest  8,000  in Tanvex BioPharma on August 31, 2024 and sell it today you would lose (1,390) from holding Tanvex BioPharma or give up 17.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tanvex BioPharma  vs.  EirGenix

 Performance 
       Timeline  
Tanvex BioPharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tanvex BioPharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
EirGenix 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in EirGenix are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, EirGenix may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Tanvex BioPharma and EirGenix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tanvex BioPharma and EirGenix

The main advantage of trading using opposite Tanvex BioPharma and EirGenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tanvex BioPharma position performs unexpectedly, EirGenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EirGenix will offset losses from the drop in EirGenix's long position.
The idea behind Tanvex BioPharma and EirGenix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments